(Q30201937)

13 August 2017

Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration "Animal Rule". (English)

1 reference

13 August 2017

0 references

1 reference

Chia-Wei Tsai

1

1 reference

PMC publication ID

4664625

13 August 2017

Stephen Morris

series ordinal

2

1 reference

13 August 2017

1 December 2015

1 reference

Frontiers in Microbiology

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

1320

1 reference

Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Monoclonal antibody therapies against anthrax

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Key aspects of the molecular and cellular basis of inhalational anthrax.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Progress and novel strategies in vaccine development and treatment of anthrax

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Raxibacumab for the treatment of inhalational anthrax

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Systematic review: a century of inhalational anthrax cases from 1900 to 2005.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Anthrax as a biological weapon, 2002: updated recommendations for management

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664625

Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis

3 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.3389%2FFMICB.2015.01320

A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3389%2FFMICB.2015.01320

21 January 2018

Raxibacumab for anthrax

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26648915

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FMICB.2015.01320

1 reference

13 August 2017

1 reference

PMC publication ID

4664625

13 August 2017

PubMed publication ID

26648915

1 reference

PMC publication ID

4664625